Interviews

Michael Cohen, RPh, MS, ScD, DPS, FASHP, President of the Institute for Safe Medicine Practices (ISMP), discusses occasions in which reporting medication errors may have negative consequences.

Michael Cohen, RPh, MS, ScD, DPS, FASHP, President of the Institute of Safe Medicine (ISMP) outlines the role pharmacists can play in reducing medication errors that occur at discharge or during other transitions of care.

Mollie Scott, PharmD, discusses how ambulatory care pharmacy services can help improve medication adherence.

Michael Cohen, RPh, MS, ScD, DPS, FASHP, President of the Institute of Safe Medicine (ISMP) discusses current medication error trends that pharmacists should be keeping an eye out for.

Adam Smith, pharmacy student at Purdue University College of Pharmacy, talks about how he became interested in pharmacy.

Michael Cohen, RPh, MS, ScD, DPS, FASHP, President of the Institute of Safe Medicine (ISMP) discusses how computerized order entry systems may be a source of medication error.

Mollie Scott, PharmD, discusses the role pharmacists can play in meeting new quality measures under a value-based care model.

Mollie Scott, PharmD, details the ways in which pharmacists can contribute to patient care in an ambulatory setting despite not having provider status.

Ethan Wahl, pharmacy student at Purdue University College of Pharmacy, talks about what he thinks is the most important issue facing pharmacy.

Mollie Scott, PharmD, describes the role of a pharmacists in providing anticoagulation resources in a transitions of care setting.

Mollie Scott, PharmD, discusses how pharmacists can help correct the problem of overscreening in patients who don't need it and reaching patient populations currently under screened for a variety of health issues.

Heather Bonome, PharmD, director of Pharmacy Segment at URAC, discusses how accreditation programs can enhance health care overall.

Peter J. Rice, PharmD, PhD, BCPS, discusses what drew him to teach pharmacy students.

Chris Topoleski, director of federal regulatory affairs for ASHP discusses how the federal compounding law will affect health-system pharmacists.

Tom Frank, PharmD, BCPS, Director of Research and Education at Area Health Education Center, discusses actions that health-system pharmacists can take to better support patient medication adherence.

Chris Topoleski, director of federal regulatory affairs for ASHP discusses how changes to the Food, Drug, and Cosmetic Act help address shortages of critical drugs.

Tom Frank, PharmD, BCPS, Director of Research and Education at Area Health Education Center, discusses products currently in the short-term development pipeline that will likely be important for health-system pharmacists.

Amanda Bright, pharmacy student at Ernest Mario School of Pharmacy at Rutgers University, talks about what qualities pharmacists should possess.

Chris Topoleski, director of federal regulatory affairs for ASHP, discusses the efforts in place to help health-system pharmacists achieve provider status under Medicare Part B. This interview was recorded at ASHP's

Tom Frank, PharmD, BCPS, Director of Research and Education at Area Health Education Center, discusses the important of new drugs currently in the development pipeline to health-system pharmacists' practice.

Jennifer Goldman, PharmD, CDE, BC-ADM, FCCP, professor of pharmacy practice at MCPHS University, discusses some strategies to overcoming patient barriers to insulin.

Chris Topoleski, director of federal regulatory affairs for ASHP, outlines the immediate impacts that achieving provider status would likely have on health-system pharmacists' practice.

David D'Altorio, PharmD, senior vice president of health services at MedImpact Healthcare Systems, Inc, discusses methods to address the growing cost of specialty medications.

Kevin Pak, pharmacy student at Philadelphia College of Pharmacy at the University of the Sciences, gives advice to students preparing to enter pharmacy school.

Peter J. Rice, PharmD, PhD, BCPS, reflects on how the industry has changed as interest in pharmacy has grown.

Tom Frank, PharmD, BCPS, Director of Research and Education at Area Health Education Center, forecasts what drugs currently in the development pipeline will be critical and relevant for health-system pharmacists.

Brian Cross, PharmD, BCACP, CDE, discusses what is more important to creating a collaborative environment: provider status or payment status.

Tom Frank, PharmD, BCPS, Director of Research and Education at Area Health Education Center, compares efficacy of warfarin and new oral anticoagulants, such as edoxaban.

Peter J. Rice, PharmD, PhD, BCPS, discusses how his school promotes interprofessional education.

Shaun Ellen Gleason, PharmD, MGS, assistant professor at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, talks about what makes a student stand out to her.